Screening for Down syndrome pregnancy using β-core fragment: Prospective study

Prenatal Diagnosis

Volumn 17, Issue 5, 1997, Pages 407-413

  Isozaki, Taichi ^a   Palomaki, Glenn E ^b   Bahado Singh, Ray O ^a   Cole, Laurence A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

core fragment; Down syndrome; Human chorionic gonadotropin; Screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; URINALYSIS;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CREATININE; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; KARYOTYPING; MASS SCREENING; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0030943540     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199705)17:5<407::AID-PD74>3.0.CO;2-Q     Document Type: Article

References (23)

1. Barkai, G., Chaki, R., Sochat, M., Goldman, B. (1991). Human chorionic gonadotrophin and trisomy 18, Am. J. Med. Genet., 41, 52-53.
2. Birken, S., Armstrong, E.G., Kolks, M.A.G., Cole, L.A., Agosto, G.M., Krichevsky, A., Canfield, R.E. (1988). The structure of the human chorionic gonadotropin β-subunit core fragment from pregnancy urine, Endocrinology, 123, 572-583.
3. Bogart, M.H., Pandian, M.R., Jones, O.W. (1987). Abnormal maternal serum hCG levels in pregnancies with fetal chromosome abnormalities, Prenat. Diagn., 7, 623-630.
4. Canick, J.A. (1990). Screening for Down syndrome using maternal serum alpha-fetoprotein, unconjugated estriol and hCG, J. Clin. Immunoassay, 13, 30-33.
5. Canick, J.A., Kellner, L.H., Saller, D.N., Jr, Palomaki, G.E., Walker, R.P., Osathanondh, R. (1995). Second trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy, Prenat. Diagn., 15, 752-759.
6. Cole, L.A. (1995). Down's syndrome screening using urine β-core fragment test; choice of immunoassay, Prenat. Diagn., 15, 679-682.
7. Cole, L.A., Kardana, A., Andrade-Gordon, P., Gawinowicz, M.A., Morris, J.C., Bergert, E.R., O'Connor, J., Birken, S. (1991). The heterogeneity of hCG: III. The occurrence, biological and immunological activities of nicked hCG, Endocrinology, 129, 1559-1567.
8. Cole, L.A., Kardana, A., Park, S.-Y., Braunstein, G.D. (1993). The deactivation of hCG by nicking and dissociation. J. Clin. Endocrinol. Metab., 76, 704-710.
9. Cole, L.A., Kardana, A., Seifer, D.B., Bohler, H.C. (1994). Urine hCG β-subunit core fragment, a sensitive test for ectopic pregnancy, J. Clin. Endocrinol. Metab., 78, 497-499.
10. Cole, L.A., Isozaki, T., Palomaki, G., Canick, J., Iles, R., Kellner, L., Saller, D.N., Jr, Cuckle, H. (1997). Detection of β-core fragment in second trimester Down's syndrome pregnancies, Rec. Adv. Prenat. Diagn. Aneuploidy, in press.
11. Cuckle, H.S., Iles, R.K., Chard, T. (1994). Urinary β-core human chorionic gonadotropin: a new approach to Down's syndrome screening. Prenat. Diagn., 14, 953-958.
12. Cuckle, H.S., Iles, R.K., Sehmi, I.H., Chard, T., Oakey, R.E., Davies, S., Ind, T. (1995). Urinary multiple marker screening for Down's syndrome. Prenat. Diagn., 15, 745-751.
13. DeMedeiros, S.F., Amato, F., Mathews, C.D., Norman, R.J. (1992). Urinary concentration of β-core fragment of hCG throughout pregnancy. Obstet. Gynecol., 80, 223-228.
14. Hayashi, M., Kozu, H. (1995). Maternal urinary β-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Prenat. Diagn., 15, 11-16.
15. Kardana, A., Cole, L.A. (1994). hCG β-subunit nicking enzymes in pregnancy and cancer patient serum, J. Clin. Endocrinol. Metab., 79, 761-767.
16. Kellner, L.H., Canick, J.A., Palomaki, G.E., Saller, D.N., Lambert-Meserlian, G.M., Neuer, M., Osathanondh, R., Bombard, A.T. (1996). Urinary markers: a new approach to screening for Down syndrome in the second trimester. Am. J. Hum. Genet., 59, A41 (207).
17. Lefort, G.P., Stolk, J.M., Nisula, B.C. (1986). Renal metabolism of the beta-subunit of human choriogonadotropin in the rat, Endocrinology, 119, 924-931.
18. Macri, J.N., Kasturi, R.V., Krantz, D.A., Cook, E.J., Moore, N.D., Young, J.A., Romero, K., Larsen, J.W., Jr. (1990). Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin, Am. J. Obstet. Gynecol., 163, 1248-1253.
19. Spencer, K. (1991). Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome, Clin. Chem., 37, 809-814.
20. Spencer, K., Macri, J.N., Anderson, R.W., Aitken, D.A., Berry, E., Crossley, J.A., Wood, P.J., Coombes, E.J., Stroud, M., Worthington, D.J. (1993). Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial, Ann. Clin. Biochem., 30, 394-401.
21. Spencer, K., Aitken, D.A., Macri, J.N., Buchanan, P.D. (1996). Urine free beta hCG and beta core in pregnancies affected by Down's syndrome, Prenat. Diagn., 16, 605-613.
22. Tanaka, A., Cole, L.A. (1994). Improved methods for detecting beta-core in normal and cancer patient urines, Clin. Chem., 40, 2317-2318.
23. Wald, N.J., Cuckle, H.S., Densem, J.W. (1988). Maternal serum unconjugated estriol as an antenatal screening test for Down syndrome. Br. J. Obstet. Gynaecol., 95, 334-335.